According to GuruFocus Insider Data, the largest CFO sells during the past week were: The Hain Celestial Group Inc., Obagi Medical Products Inc. and Cardinal Health Inc.
The Hain Celestial Group Inc. (HAIN, Financial): Executive Vice President and CFO Ira J. Lamel Sold 109,084 Shares
Executive Vice President and CFO Ira J. Lamel sold 109,084 shares of HAIN stock on 09/10/2012 at the average price of $72.26. Ira J. Lamel owns at least 36,066 shares after this. The price of the stock has decreased by 5.96% since.
The Hain Celestial Group is a natural, specialty and snack food company. The Hain Celestial Group Inc. has a market cap of $3.09 billion; its shares were traded at around $67.95 with a P/E ratio of 37.9 and P/S ratio of 2.2. The Hain Celestial Group Inc. had an annual average earnings growth of 4.5% over the past 10 years.
The Hain Celestial Group has released its fourth quarter 2012 results. In this quarter, the company had net sales from continuing operations of $350.8 million, a 22.3% increase compared to its sales of $286.9 million prior year quarter. The company reported net income of $23.4 million ($0.50 per share), compared to $12.8 million ($0.28) in the same quarter last year. Operating free cash flow was $101.5 million, and GAAP operating margin rose 96 basis points from prior year quarter.
Senior Vice President and Chief Accounting Officer Michael J. Speiller sold 15,000 shares of HAIN stock on 09/10/2012 at the average price of $71.36.
Obagi Medical Products Inc. (OMPI, Financial): CFO and Executive Vice President Preston S. Romm Sold 95,471 Shares
CFO and Executive Vice President Preston S. Romm sold 95,471 shares of OMPI stock on 09/11/2012 at the average price of $13.22. The price of the stock has decreased by 3.25% since.
Obagi Medical Products Inc. develops and commercializes skin health products for the dermatology, plastic surgery, and related aesthetic markets. Obagi Medical Products Inc. has a market cap of $250.3 million; its shares were traded at around $12.79 with a P/E ratio of 14.1 and P/S ratio of 2.2.
Obagi Medical Products Inc. has released its second quarter 2012 results ended June 30, 2012. Net sales for this quarter increased 6% from last year to $30.5 million. Net income was $3.4 million ($0.18 per share), compared to $2.9 million ($0.16 per share) prior year quarter.
Cardinal Health Inc. (CAH, Financial): CFO Jeffrey William Henderson Sold 79,410 Shares
CFO Jeffrey William Henderson sold 79,410 shares of CAH stock on 09/10/2012 at the average price of $38.32. Jeffrey William Henderson owns at least 110,279 shares after this. The price of the stock has increased by 0.13% since.
Cardinal Health Inc. is one of the providers of products and services to healthcare providers and manufacturers to help them improve the efficiency and quality of healthcare. Cardinal Health Inc. has a market cap of $13.69 billion; its shares were traded at around $38.37 with a P/E ratio of 12.3 and P/S ratio of 0.1. The dividend yield of Cardinal Health Inc. stocks is 2.4%. Cardinal Health Inc. had an annual average earnings growth of 0.2% over the past 10 years.
Cardinal Health Inc. reported fourth quarter 2012 revenues of $26.8 billion and non-GAAP diluted EPS of $0.73.
For the complete list of stocks that Sold by their CFOs, go to: Insider Buys.
The Hain Celestial Group Inc. (HAIN, Financial): Executive Vice President and CFO Ira J. Lamel Sold 109,084 Shares
Executive Vice President and CFO Ira J. Lamel sold 109,084 shares of HAIN stock on 09/10/2012 at the average price of $72.26. Ira J. Lamel owns at least 36,066 shares after this. The price of the stock has decreased by 5.96% since.
The Hain Celestial Group is a natural, specialty and snack food company. The Hain Celestial Group Inc. has a market cap of $3.09 billion; its shares were traded at around $67.95 with a P/E ratio of 37.9 and P/S ratio of 2.2. The Hain Celestial Group Inc. had an annual average earnings growth of 4.5% over the past 10 years.
The Hain Celestial Group has released its fourth quarter 2012 results. In this quarter, the company had net sales from continuing operations of $350.8 million, a 22.3% increase compared to its sales of $286.9 million prior year quarter. The company reported net income of $23.4 million ($0.50 per share), compared to $12.8 million ($0.28) in the same quarter last year. Operating free cash flow was $101.5 million, and GAAP operating margin rose 96 basis points from prior year quarter.
Senior Vice President and Chief Accounting Officer Michael J. Speiller sold 15,000 shares of HAIN stock on 09/10/2012 at the average price of $71.36.
Obagi Medical Products Inc. (OMPI, Financial): CFO and Executive Vice President Preston S. Romm Sold 95,471 Shares
CFO and Executive Vice President Preston S. Romm sold 95,471 shares of OMPI stock on 09/11/2012 at the average price of $13.22. The price of the stock has decreased by 3.25% since.
Obagi Medical Products Inc. develops and commercializes skin health products for the dermatology, plastic surgery, and related aesthetic markets. Obagi Medical Products Inc. has a market cap of $250.3 million; its shares were traded at around $12.79 with a P/E ratio of 14.1 and P/S ratio of 2.2.
Obagi Medical Products Inc. has released its second quarter 2012 results ended June 30, 2012. Net sales for this quarter increased 6% from last year to $30.5 million. Net income was $3.4 million ($0.18 per share), compared to $2.9 million ($0.16 per share) prior year quarter.
Cardinal Health Inc. (CAH, Financial): CFO Jeffrey William Henderson Sold 79,410 Shares
CFO Jeffrey William Henderson sold 79,410 shares of CAH stock on 09/10/2012 at the average price of $38.32. Jeffrey William Henderson owns at least 110,279 shares after this. The price of the stock has increased by 0.13% since.
Cardinal Health Inc. is one of the providers of products and services to healthcare providers and manufacturers to help them improve the efficiency and quality of healthcare. Cardinal Health Inc. has a market cap of $13.69 billion; its shares were traded at around $38.37 with a P/E ratio of 12.3 and P/S ratio of 0.1. The dividend yield of Cardinal Health Inc. stocks is 2.4%. Cardinal Health Inc. had an annual average earnings growth of 0.2% over the past 10 years.
Cardinal Health Inc. reported fourth quarter 2012 revenues of $26.8 billion and non-GAAP diluted EPS of $0.73.
For the complete list of stocks that Sold by their CFOs, go to: Insider Buys.
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.
